000 01617 a2200457 4500
005 20250514045325.0
264 0 _c20021203
008 200212s 0 0 eng d
022 _a0012-1797
024 7 _a10.2337/diabetes.51.10.3025
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAnderwald, Christian
245 0 0 _aEffects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle.
_h[electronic resource]
260 _bDiabetes
_cOct 2002
300 _a3025-32 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aBlood Glucose
_xmetabolism
650 0 4 _aDiabetes Mellitus, Type 2
_xdrug therapy
650 0 4 _aFatty Acids, Nonesterified
_xmetabolism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xadministration & dosage
650 0 4 _aInsulin
_xadministration & dosage
650 0 4 _aInsulin Resistance
650 0 4 _aLiver
_xmetabolism
650 0 4 _aMagnetic Resonance Spectroscopy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMuscle, Skeletal
_xmetabolism
700 1 _aBernroider, Elisabeth
700 1 _aKrssak, Martin
700 1 _aStingl, Harald
700 1 _aBrehm, Attila
700 1 _aBischof, Martin G
700 1 _aNowotny, Peter
700 1 _aRoden, Michael
700 1 _aWaldhäusl, Werner
773 0 _tDiabetes
_gvol. 51
_gno. 10
_gp. 3025-32
856 4 0 _uhttps://doi.org/10.2337/diabetes.51.10.3025
_zAvailable from publisher's website
999 _c12164122
_d12164122